IBM-powered advanced computation used to improve light-activated chemotherapy

University of Toronto Professor, Vaughn Betz is helping Ontario-based medical device manufacturer, Theralase Technologies improve the effectiveness of light-activated cancer treatment. According to Betz, the SOSCIP collaboration’s efforts focus on using advanced computation to rapidly simulate what's going to happen when light probes are placed in certain places of the patients’ body.

Transcript

 

June 22, 2017

Share on

Feedback: Was this page useful?

Talk to a business consultant


Request a conversation

Subscribe to our newsletter


Sign up now

Newsletter Sign Up

Form is for business purposes.

Back to top